Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

GRI Bio, Inc.

NASDAQ: GRI · Life Sciences · 2 alerts · CIK 1824293

Share price
$1.40Close, Nov 16
Market cap
$3.06M
Shares outstanding
2.19MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All GRI Bio, Inc. filings on SEC EDGAR ↗

5:12 PM ET 10-Q
Financial Results

GRI Bio Q3 2026 Results: Net Loss of $1.51M, Loss Narrows

GRI Bio, Inc. reported a net loss of $5.15 million for the nine months ended September 30, 2026, a significant reduction from the $9.30 million loss in the prior year period, primarily due to lower research and development expenses. The company strengthened its liquidity through an ATM offering, ending the period with $9.47 million in cash and cash equivalents. GRI Bio remains a clinical-stage biopharmaceutical company with an accumulated deficit of $56.84 million and no significant revenue.

Key figure
Net loss $1.51M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.